Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin Blood Concentration and Efficacy in Invasive Candida Infection
ChiCTR2000033905Phase 4Recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-Sen University
- Start
- Jun 2020
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of caspofungin in invasive candidiasis, sponsored by The Seventh Affiliated Hospital, Sun Yat-Sen University. Primary endpoint: G test. Started Jun 2020; status: recruiting.
02
Drugs
caspofungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on ChiCTR2000033905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033905.